MedicalDaily Evidence Check The evidence base for BPC-157, TB-500, and MOTS-C consists of animal studies, small pilot human trials, and anecdotal clinical reports, none of which meet the standard of a Phase 3 randomized controlled trial required for FDA drug approval
Actual BAC levels can vary based on various factors, and the calculators estimate should be used as a guide rather than an exact measurement
Figure 3 shows it can lead to tiredness, weak muscles, digestive problems, nerve damage, headaches, trouble thinking, mood changes, and tingling in the hands and feet
In the research context, GHK-Cu is a tool for asking questions about copper delivery to specific copper-dependent enzymes (notably lysyl oxidase) and for studying the cellular consequences of GHK-mediated copper supply
doi: 10.1186/s12876-023-02693-8